Market Overview

Global Tuberculosis Diagnostics Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 4.5% - ResearchAndMarkets.com

Share:

The "Global
Tuberculosis Diagnostics Market - Segmented by Diagnostic Test Type, End
User, and Geography - Growth, Trends, and Forecast (2018 - 2023)"

report has been added to ResearchAndMarkets.com's
offering.

The global tuberculosis diagnostics market is expected to register a
CAGR of nearly 4.5%, during the forecast period of 2018-2023.

According to the World Health Organization (WHO), about 10 million
people are affected by tuberculosis, each year. Further, tuberculosis is
the leading cause of death from a single infectious agent, ranking above
HIV/AIDS. In addition, the WHO also states that the developing economies
of Asia-Pacific, Africa, and Latin America account for the major burden
related to tuberculosis, MDR TB, and TB associated with HIV, as of 2017.
As per a 2017 report of the WHO, about 153,000 patients with
MDR/rifampicin resistant (RR) TB were detected worldwide, in 2016.

The cost associated with tuberculosis diagnostics varies across
laboratories and hospitals, globally. According to Unitaid, the use of
GeneXpert MTB/RIF is primarily hampered owing to its high cost,
particularly in the emerging markets. Further, China and India were
among the countries that reflect higher costs of tests and increased
expansion of the private sector. This is further linked with the
unavailability of proper laboratory capacities.

Owing to the presence of a large, diversified patient population and
high burden of tuberculosis, Asia-Pacific is expected to retain its
market position, over the forecast period. Countries, such as India,
China, Indonesia, and Afghanistan are among the top-priority countries
for the control of communicable diseases, according to the WHO. China
and India registered the highest number new cases of tuberculosis
annually, followed by African and Latin American countries.

Companies Mentioned

  • Abbott
  • Becton
  • Dickinson and Company
  • BioMrieux SA
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Qiagen
  • Siemens
  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/vgxp43/global?w=4

View Comments and Join the Discussion!